Company Filing History:
Years Active: 1980-1984
Title: Albert Ziering: Innovator in Pharmaceutical Chemistry
Introduction
Albert Ziering is a notable inventor based in Nutley, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 3 patents that focus on innovative compounds with significant therapeutic potential. His work primarily revolves around the development of antipsychotic and anti-inflammatory agents.
Latest Patents
Ziering's latest patents include the development of substituted (10H-phenothiazin-10-L)-propyl-1-piperazines. These compounds are described as having a piperazine moiety combined by an ether linkage to various phenolic moieties, making them useful as orally active long-lasting antipsychotic agents. Another significant patent involves dibenzothiophenes, which are prepared from substituted thiophenol and haloketocyclohexane. These dibenzothiophenes are recognized for their utility as anti-inflammatory, analgesic, and antirheumatic agents.
Career Highlights
Albert Ziering has made substantial contributions to the field of pharmaceutical research during his career. He is currently associated with Hoffmann-La Roche Inc., where he continues to innovate and develop new therapeutic agents. His work has had a lasting impact on the pharmaceutical industry, particularly in the area of mental health and pain management.
Collaborations
Ziering has collaborated with notable colleagues, including Leo Berger and John T Plati. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Albert Ziering's innovative work in pharmaceutical chemistry has led to the development of important therapeutic agents. His contributions continue to influence the field and improve patient outcomes.